More Post from the Author
- Huawei Cloud: Fornire ai clienti gli strumenti per avere successo nei mercati globali attraverso l'innovazione continua
- Sasken Partners with VicOne to Deliver End-to-End Automotive Cybersecurity Solutions
- Helser Brothers to Showcase the One-of-a-Kind Motorized French Pole at CWC 2025
- ProCap BTC Announces Executive Team and Appreciation of its Bitcoin Holdings by More Than $60 Million in Less Than 90 Days
- One Park Financial Earns Great Place to Work Certification for the Eighth Time
Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System
Published on Mon 3 Feb 2025 2:31:05 UTC
Company Contact Information
Consumers:
866-770-3024
[emailprotected]
Press:
[emailprotected]
MORRISTOWN, N.J., Jan. 31, 2025 /PRNewswire/ -- Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for the recall is that there is a potential that patches could be multi-stacked, adhered one on top of the other, in a single product pouch. This transdermal system is manufactured by Kindeva Drug Delivery L.P., Northridge, CA and is distributed by Alvogen, Inc. as a private label distributor.
More Post from the Author
- Huawei Cloud: Fornire ai clienti gli strumenti per avere successo nei mercati globali attraverso l'innovazione continua
- Sasken Partners with VicOne to Deliver End-to-End Automotive Cybersecurity Solutions
- Helser Brothers to Showcase the One-of-a-Kind Motorized French Pole at CWC 2025
- ProCap BTC Announces Executive Team and Appreciation of its Bitcoin Holdings by More Than $60 Million in Less Than 90 Days
- One Park Financial Earns Great Place to Work Certification for the Eighth Time